Sponsor content
110 result(s) found, displaying 31 to 40
-
Prescription medicine decision summaryTGA decision: Sunlenca (lenacapavir sodium) is approved to treat multidrug resistant HIV-1 infection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets blister pack.
-
Prescription medicine registrationActive ingredients: lenacapavir sodium.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag.
-
-
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: T Cells - axicabtagene ciloleucel, cryopreserved - T - Yescarta.